Macro analysts are forecasting that Bitcoin (BTC) could dip below $70,000, driven by hawkish monetary policies in Japan that are influencing global liquidity and risk sentiment. As market trends adapt to evolving international economic signals, this prediction highlights the interconnectedness of crypto with traditional finance.Macro analysts are forecasting that Bitcoin (BTC) could dip below $70,000, driven by hawkish monetary policies in Japan that are influencing global liquidity and risk sentiment. As market trends adapt to evolving international economic signals, this prediction highlights the interconnectedness of crypto with traditional finance.

Macro Analysts Predict Bitcoin May Drop Below $70K Due to Hawkish Policies in Japan

2025/12/15 16:20
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Keywords: Bitcoin price drop $70K, hawkish Japan policies Bitcoin, macro analysts BTC prediction, global economic signals crypto, Bitcoin market trends

Macro analysts are forecasting that Bitcoin (BTC) could dip below $70,000, driven by hawkish monetary policies in Japan that are influencing global liquidity and risk sentiment. As market trends adapt to evolving international economic signals, this prediction highlights the interconnectedness of crypto with traditional finance.

Analysts' Predictions on Bitcoin's Price
Leading macro experts, including those from JPMorgan and Bloomberg Intelligence, warn of a potential BTC pullback below $70K. Currently trading around $75,000 after recent highs, Bitcoin faces headwinds from Japan's shift toward tighter policy. The Bank of Japan (BoJ) has signaled rate hikes and reduced bond purchases to combat inflation, strengthening the yen and prompting capital outflows from risk assets like crypto.

This hawkish stance contrasts with dovish policies elsewhere, creating currency volatility. Analysts note that a stronger yen could lead to "carry trade" unwinds, where investors sell high-yield assets (including BTC) to repay yen-denominated loans, suppressing prices.

Impact of Japan's Policies on Global Markets
Japan's policy pivot is rippling through markets. As the third-largest economy, its actions affect global liquidity—tighter conditions reduce available capital for speculative investments like Bitcoin. Historical patterns show BTC sensitivity to such shifts; for instance, similar BoJ moves in 2022 contributed to crypto winter dips.

Macro signals, including US Fed rate expectations and China's stimulus, are also in play, but Japan's hawkishness adds downward pressure. "Bitcoin's rally may pause below $70K as Japan tightens," said Bloomberg macro strategist Mike McGlone.

Evolving Market Trends and Crypto Response
Despite the prediction, BTC has shown resilience, with ETF inflows and halving effects providing support. However, trends like declining trading volumes and rising volatility indexes suggest caution. If BTC breaks $70K support, it could test $60K levels, per technical charts.

On the flip side, if global signals turn positive (e.g., US rate cuts), a rebound is possible. Investors are watching BoJ meetings and yen strength closely.

Implications and Advice for Crypto Investors
This forecast underscores crypto's vulnerability to macro events. Diversify holdings and monitor global policies. While bearish near-term, long-term fundamentals like adoption remain strong. Stay updated on macro analysts BTC prediction and global economic signals crypto for informed decisions—volatility is inherent in markets.

Disclaimer: The articles published on this page are written by independent contributors and do not necessarily reflect the official views of MEXC. All content is intended for informational and educational purposes only and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC. Cryptocurrency markets are highly volatile — please conduct your own research and consult a licensed financial advisor before making any investment decisions.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09